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690Objective: We evaluated the efficacy of minimally manipulative surgical strategies to harvest the saphenous
vein for use in a Y-composite graft based on the left internal thoracic artery in terms of preservation of endothe-
lial structure and function.
Methods: Twenty patients who underwent off-pump coronary revascularization using the saphenous vein in
a Y-composite graft based on the left internal thoracic artery were studied. The saphenous vein was harvested
from each patient with minimal manipulation. An excess saphenous vein segment was removed before dilatation
(control group), and a second segment was removed after dilation performed using a pressure-sensing syringe
(conventional group). A third segment was obtained from a Y-composite vein graft dilated by flow and pressure
from the left internal thoracic artery (composite group). Hematoxylin–eosin staining and immunohistochemistry
using antibodies against CD31, CD34, von Willebrand factor, and endothelial nitric oxide synthase were per-
formed. A generalized estimating equation was adopted for statistical analysis.
Results: Histologic and immunohistochemical studies revealed better endothelial preservation in the composite
and control groups than in the conventional group (P< .01 in each). The composite group saphenous vein
showed a lower grade of endothelial integrity than the control group saphenous vein based on hematoxylin–eosin
staining, CD34 immunohistochemistry, and nitric oxide synthase staining (P<.001 in each).
Conclusions:Harvesting of the saphenous vein usingminimal manipulation for use in a Y-composite graft based
on the left internal thoracic artery preserved endothelial structure and function when compared with manually
dilated saphenous vein harvesting. (J Thorac Cardiovasc Surg 2012;144:690-6)The saphenous vein (SV) is limited in its use as a bypass
conduit in coronary artery bypass grafting (CABG) when
compared with arterial grafts because of structural and
functional differences between veins and arteries.1 Lower
long-term graft patency rates and worse clinical outcomes
have been reported after CABG performed with SV grafts
compared with CABG performed with arterial grafts, such
as the internal thoracic artery (ITA) and right gastroepiploic
artery.2-4 However, the SV is still a widely used conduit of
choice because of its numerous advantages, including
ease of access and manipulation, sufficient length for
grafting, and short harvesting time.
A variety of efforts to overcome poor long-term patency
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The Journal of Thoracic and Cardiovascular Surgtechnique, in which manipulation during harvesting and
anastomosis of the SV is minimized, was one of these
efforts.11 A novel ‘‘no-touch’’ technique was recently intro-
duced that demonstrated an improved patency rate.10 In ad-
dition to the choice of harvesting technique, previous
reports have also suggested that the surgical strategy of us-
ing the ascending aorta as a proximal anastomotic site for
a bypass graft may have a causal effect on poor long-term
patency rates of SV grafts.1,12,13 Using the SV as part of
a composite graft theoretically could provide an
advantage in that the SV would be well preserved as
a result of less exposure to pressure and circulatory
stress.13 However, only a few studies using the SV in a com-
posite graft have been conducted.14,15 One previous
retrospective study demonstrated improved patency rates
of SV composite grafts at 1 year, compared with an earlier
report of poor patency rates for SVaortocoronary grafts.3,15
The aim of this study was to evaluate the benefits of min-
imally manipulative surgical techniques for harvesting the
SV and using it to create a Y-composite graft based on the
in situ left ITA in terms of preservation of venous endothe-
lial structure and function.MATERIALS AND METHODS
The study protocol was approved by the institutional review board (ap-
proval no. H-0803-024-237), and informed consent was obtained from all
study patients.ery c September 2012
TABLE 1. Preoperative characteristics and risk factors of the study
patients and nonstudy patients
Study patients
(n ¼ 20)
Non-study patients
(n ¼ 58)
P
value
Age (y) 61.0  7.6 66.2  9.4 .029
Female 6 (30.0%) 10 (17.2%) .334
Risk factors, n (%)
Smoking 10 (50.0%) 25 (43.1%) .593
Hypertension 15 (75.0%) 42 (72.4%) .822
Diabetes mellitus 7 (35.0%) 29 (50.0%) .246
Dyslipidemia 3 (15.0%) 7 (12.1%) .711
Overweight (BMI  25) 10 (50.0%) 22 (37.9%) .334
History of stroke 1 (5.0%) 5 (8.6%) >.999
Chronic renal failure 0 (0.0%) 2 (3.4%) >.999
LVEF<35% 1 (5.0%) 10 (17.2%) .272
Unstable angina 14 (70.0%) 35 (60.3%) .441
Left main disease 11 (55.0%) 26 (44.8%) .432
3-vessel disease 12 (60.0%) 45 (77.6%) .126
BMI, Body mass index (kg/m2); LVEF, left ventricular ejection fraction.
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
eNOS ¼ endothelial nitric oxide synthase
ITA ¼ internal thoracic artery
SV ¼ saphenous vein
vWF ¼ von Willebrand factor
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From February 2009 to December 2009, 78 patients underwent primary
isolated off-pump CABG using the SVas part of a Y-composite graft based
on the in situ left ITA. Twenty of those patients, in whom the harvested SV
from a lower limb was long enough to obtain approximately 30 mm of ex-
cess SV segment after revascularization was completed, were enrolled in
the present study for histologic evaluation of the SV portion of the graft.
Mean patient age at the time of surgery was 61.0 7.6 years. Preoperative
demographic data of the 20 study patients were similar to those of the other
58 patients who underwent off-pump CABG using SV Y-composite grafts
during the study period, with the exception of a younger mean age of the
study patients (Table 1).
Operative Technique
The basic surgical procedures and principles of off-pump CABG and
harvesting technique of the SV have been described.15,16 The left ITA
was harvested using a skeletonization technique. The left ITA was then
immersed in a 10-mL syringe filled with warm diluted papaverine saline
solution (1 mg/mL) to dilate pharmacologically until use. We did not use
intraluminal injection of papaverine solution. The SV was harvested as
a second graft and anastomosed to the side of the in situ left ITA to con-
struct a Y composite graft. The SV from a lower leg was chosen for use
in grafting as opposed to the upper leg SV so that the possibility of size mis-
match with native coronary arteries or ITAwas decreased. Saphenous vein
harvest was initiated after systemic heparinization during harvest of the left
ITA andwas performed using an atraumatic, open technique, so that manip-
ulation with micro-forceps was limited to the perivascular tissue and never
included the full thickness of the venous wall. Side branches were divided
after metal clipping. To prevent inadvertent endothelial injury, clips were
applied at least 1 mm apart from branch origins. Tension on the SV was
minimized during harvest, and manual intraluminal dilatation was avoided.
Immediately after the SV was harvested, it was used to construct a Y-com-
posite graft without any pharmacologic treatment. After the Y-composite
graft was constructed, the distal end of the SV was clamped with an atrau-
matic bulldog (Scanlan International Inc, St Paul, Minn) and left to be di-
lated spontaneously by the native flow and pressure of the left ITA.
The left anterior descending coronary artery territory was revascular-
ized first. A sequential anastomotic technique using each Y-composite graft
side-arm was almost always used for complete revascularization when
more than 2 coronary arterial anastomoses were needed. Patients were
given an initial dose of heparin (1.5 mg/kg) and periodic supplemental
doses to maintain an activated clotting time of more than 300 seconds.
All patients received aspirin therapy until the day of surgery and resumed
it as soon as possible after surgery, usually 1 day postoperatively.
Preparation of the Saphenous Vein for Histologic
Evaluation
Of the 16 to 18 cm of SV harvested from a lower leg for grafting, ap-
proximately 30 mm of excess SV near the knee level were used for this
study. A 5-mm segment of the 30 mm was removed before dilation (con-
trol group). A 20-mm segment of the 30 mm was dilated by manual injec-
tion of papaverine (1 mg/mL) saline solution with a pressure-sensingThe Journal of Thoracic and Casyringe (DLP Inc, Grand Rapids, Mich) connected to a manometer (con-
ventional group). Mean pressure applied for manual dilation of the 20 mm
segment was 271  53 mm Hg in the conventional group. After a Y-com-
posite graft was constructed, an atraumatic clamp was applied at the distal
end of the SV graft segment, leaving the SV portion of the graft exposed
to the native blood flow and pressure of the in situ left ITA for dilation
during the distal anastomoses. The average systolic, diastolic, and mean
blood pressures during distal anastomoses were 108  9 mm Hg, 59 
6 mm Hg, and 74  5 mm Hg, respectively. Immediately before perform-
ing the far distal anastomosis, 5 mm of the distal segment of the SV graft
that had been dilated by the native ITA pressure was removed and pre-
pared for histologic evaluation (composite group). The distal end of the
SV graft was exposed to the native ITA flow and pressure for an average
of 83  32 minutes.
All samples were fixed with 10% formalin solution, embedded in par-
affin, and cut into 5 mm-thin sections. Hematoxylin–eosin staining was per-
formed for evaluation of the SV endothelium. Immunohistochemistry was
performed using mouse monoclonal antibodies against human endothelial
glycoprotein CD31 (1:25, Santa Cruz Biotechnology, Inc, Santa Cruz, Ca-
lif), CD34 (1:10, Cell Signaling Technology, Inc, Boston, Mass), von Wil-
lebrand factor (vWF 1:200, Dako, DK-2600 Glostrup, Denmark), and
endothelial nitric oxide synthase (eNOS 1:50, R&D Systems, Inc, Minne-
apolis, Minn). Endogenous peroxidase activity of the sections was blocked
by 10-minute preincubation within 3% hydrogen peroxide in methanol.
Sections were then incubated in 5% normal goat serum in Tris buffer so-
lution at room temperature for 10 minutes to block background staining.
They were then incubated in mouse monoclonal antibodies against
CD31, CD34, and vWF for 30 minutes to evaluate structural integrity
and eNOS to evaluate endothelial function. The sections were rinsed,
and secondary antibody conjugated with horseradish peroxidase was ap-
plied for 30 minutes. After staining with diaminobenzidine chromogen
for 10 minutes and counterstaining with Mayer’s hematoxylin for 15 sec-
onds, the sections were prepared for microscopic examination. The amount
of positive staining was graded from 1 to 10, based on the percentage of
positive staining of the lumen length (Table 2).
Statistical Analysis
Data were expressed as mean standard deviation, median and ranges,
or proportions. Comparisons between the 2 groups were made using the
chi-square test and Fisher exact test for categoric variables and Student t
test for continuous variables. Generalized estimating equation analysisrdiovascular Surgery c Volume 144, Number 3 691
TABLE 2. Semiquantitative grading criteria of endothelial staining
Grade % of luminal length
1 0–10
2 10–20
3 20–30
4 30–40
5 40–50
6 50–60
7 60–70
8 70–80
9 80–90
10 90–100
FIGURE 1. Hematoxylin–eosin staining of luminal endothelium of the
SV in the control (A), conventional (B), and composite groups (C)
(3200). Note the defects in staining (black arrows), particularly in the con-
ventional group.
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Swas used to compare the degree of stain among the 3 groups. Adjusted
P value using the Hochberg method was calculated for each staining
method. A P value of<.05 was considered statistically significant.
RESULTS
Generalized estimating equation analysis revealed signif-
icant differences in the grades of staining between the
groups and between the staining methods (P< .001 and
P ¼ .003, respectively). Because there was a significant in-
teraction between the groups and staining methods
(P ¼ .037), P values of differences in the grades of staining
between groups were calculated for each staining method
and adjusted using the Hochberg correction method.
Histologic Study
Hematoxylin–eosin stain revealed a higher grade of well-
preserved endothelial cells in the composite group than in
the conventional group (grades 7.4  2.5 vs 5.0  2.0,
P<.001). However, the composite group grade was lower
than the control group grade (grades 7.4  2.5 vs 9.2 
0.8, P<.001) (Figure 1).
Immunohistochemical Study
There were no significant differences in the grades of im-
munohistochemistry using CD31 antibody between the
control and composite groups (9.0  1.5 and 9.0  1.5, re-
spectively; P¼ .653). The grades of immunohistochemistry
using CD31 antibody in both the control and composite
groups were significantly higher than in the conventional
group (6.9 2.5), suggesting poorly preserved endothelium
in the conventional group (P<.001). Immunohistochemis-
try using vWF antibody revealed better preserved endothe-
lium in both the control and composite groups than in the
conventional group (control, composite, and conventional
groups; grades 8.4  1.9, 8.2  2.0, and 6.7  2.7, respec-
tively; P<.001) (Figures 2 and 3). Immunohistochemistry
using CD34 antibody revealed similar results to those seen
by hematoxylin–eosin staining. Although endothelial
integrity in the composite group was preserved better than
in the conventional group (P < .001), it was preserved
worse than in the control group (P < .001) (Figure 4).692 The Journal of Thoracic and Cardiovascular SurgEndothelial function evaluated with immunohistochemical
stain against eNOS showed similar results with CD34 stain-
ing; eNOS in the composite group was preserved better than
in the conventional group (P<.001), but was less preserved
than in the control group (P<.001) (Figure 5) (Table 3).ery c September 2012
FIGURE 2. Luminal endothelium of the SV in the control (A), conven-
tional (B), and composite groups (C). CD31 was stained as a brown color
(A, B:3200; C:3100). Note the defects in staining (black arrows), partic-
ularly in the conventional group.
FIGURE 3. Luminal endothelium of the SV in the control (A), conven-
tional (B), and composite groups (C). vWF was stained as a brown color
(3100). Note the defects in staining (black arrows), particularly in the con-
ventional group.
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SDISCUSSION
The present study revealed that surgical strategies to har-
vest the SV with a minimally manipulative surgical tech-
nique for use in a Y-composite graft based on the in situ
left ITA were beneficial in preserving endothelial structure
and function of the SV portion of the graft.The Journal of Thoracic and CaThe SV is a widely used conduit that offers advantages of
ease of access and manipulation, sufficient length, and short
harvesting time. However, poorer long-term patency rates
and clinical outcomes have been reported after CABG per-
formed using SV grafts compared with those after CABGrdiovascular Surgery c Volume 144, Number 3 693
FIGURE 4. Luminal endothelium of the SV in the control (A), conven-
tional (B), and composite groups (C). CD34 was stained as a brown color
(A:3200; B, C:3100). Note the defects in staining (black arrows), partic-
ularly in the conventional group.
FIGURE 5. Luminal endothelium of the SV in the control (A), conven-
tional (B), and composite groups (C). eNOS was stained as a brown color
(3100). Note the defects in staining (black arrows), particularly in the con-
ventional group.
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Swith arterial grafts, such as the ITAs and right gastroepiploic
artery.2-4 Major limitations in using the SVas a bypass graft
originate from structural and functional differences between
veins and arteries.1 Chronic endothelial damage and694 The Journal of Thoracic and Cardiovascular Surgdysfunction stimulate migration and proliferation of smooth
muscle cells into the intima, a key event in the development
of atherosclerosis and graft failure of the SV.17Methods used
to improve patency of SV grafts included pharmacologicery c September 2012
TABLE 3. Group comparisons
Stain
Control
group
Conventional
group
Composite
group
Hematoxylin–eosin 9.2  0.8* 5.0  2.0 7.4  2.5*,y
CD31 9.0  1.5* 6.9  2.5 9.0  1.5*
vWF 8.4  1.9* 6.7  2.7 8.2  2.0z
CD34 7.8  1.7* 2.6  2.0 5.0  3.0*,y
eNOS 9.5  0.9* 3.6  2.1 6.5  3.1*,y
Comparison of luminal staining of native SVs (control group), SV grafts harvested
using a conventional method (conventional group), and those harvested with a mini-
mal manipulation surgical technique and anastomosed to the left ITA (composite
group). *Significant difference compared with the conventional group (P< .001).
ySignificant difference compared with the control group (P< .001). zSignificant
difference compared with the conventional group (P ¼ .003).
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Srelaxation of the SVafter harvest and strict medical therapy,
including administration of antiplatelet and lipid-lowering
agents after surgery.18,19 Further efforts to improve patency
of the SV have continued, including external support using
stents, intraoperative gene transfer, and improvement in
harvesting technique.5-10
In addition to the harvesting technique, previous reports
have suggested that the surgical strategy of using the as-
cending aorta for the proximal anastomotic site of a bypass
graft may have an effect on poor long-term patency rates of
the SV graft.1,12,13 Theoretic advantages of using the SVas
part of a composite graft over an aortocoronary bypass graft
are 1) the SV graft anastomosed to the left ITA may be
exposed to less pressure trauma than a graft anastomosed
to the ascending aorta, and 2) the risk of atherosclerotic
disease is reduced by the constant exposure of the SV
graft to nitric oxide produced from the left ITA.12,13 In
a previous study performed by our group, similar patency
rates of SV composite grafts and arterial composite grafts
were demonstrated.15 Early and 1-year patency rates of
SV composite grafts were 97.1% (132/136) and 92.1%
(105/114), respectively, which were not significantly differ-
ent from those of arterial composite grafts. On the contrary,
we had demonstrated poor patency rates of the SV when
used as part of aortocoronary grafts (95.9% [116/121]
and 76.0% [92/121] early and at 1 year, respectively).3
Our surgical strategies to preserve the SV from endothe-
lial injury included changing harvesting technique and us-
ing the SV as part of a Y-composite graft. We harvested
the SVafter systemic heparinization to prevent microthrom-
bus formation on the venous endothelium during harvest.
Manipulation and tension were minimized, and dilatation
using a pressure-sensing syringe was avoided because
mean pressure applied for manual dilation with a pres-
sure-sensing syringe was higher than expected as presented
in this study. Instead, the SV graft was connected to the side
of the in situ left ITA to be dilated spontaneously by the na-
tive flow and pressure.15
Of numerous endothelial markers, CD31, CD34, and
vWF are the most commonly used markers for evaluatingThe Journal of Thoracic and Cavascular endothelial structural integrity. However, limited
data are available on the immunohistochemical expression
pattern in normal endothelium. Previous studies have re-
ported that CD31 was strongly and homogeneously ex-
pressed in pulmonary vascular endothelial tissue.20-22
Conversely, CD34 and vWF were more heterogeneous in
distribution; CD34 was expressed more strongly in
capillaries and arteries, and vWF was expressed mainly
in venous endothelia. Another study reported that the
expression of endothelial cell markers CD31, CD34, and
vWF in the vascular tree was heterogeneous, with
specific patterns for individual vessel types and different
anatomic compartments of the same organ.20 In the present
study, histologic examination was performed with multiple
markers, including hematoxylin–eson staining and immu-
nohistochemistry performed using monoclonal antibodies
against CD31, CD34, and vWF to overcome the limitations
of different expressions of endothelial markers. Antibodies
against eNOS were used for evaluation of endothelial func-
tion. The SV grafts that were harvested using a minimally
manipulative surgical technique and exposed to the native
flow of the ITA (composite group) showed better preserva-
tion of endothelial integrity and function compared with
those treated with a conventional method (conventional
group). These results were in agreement with recent
studies demonstrating histologic differences between con-
ventionally harvested SVs and those harvested using a no-
touch surgical technique.23,24 In previous studies, however,
the SVs were prepared for histologic evaluation
immediately after harvest. The possible detrimental
effect of direct aortic pressure on the SV endothelium
was not evaluated.Study Limitations
There are several limitations to the present study that
must be recognized. First, the SV was exposed to the native
flow for only a short time. Second, we did not compare our
results with SVs used as aortocoronary grafts because our
surgical strategy was to avoid aortic manipulation, if possi-
ble. During the study period, only 3 patients underwent iso-
lated CABG using the SV for aortocoronary bypass. Third,
correlation of long-term angiographic patency with histo-
logic results in a large patient population might be neces-
sary to demonstrate that the preserved SV endothelium
has any effect on long-term patency rates of SV composite
grafts. Fourth, we evaluated only structure and function of
the endothelial layer, and did not examine conduit behavior
in an isolated bath to test function of both endothelium and
smooth muscle.References
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